These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25434191)

  • 1. [Modeling of schizophrenia with Levodopa + Carbidopa].
    Kucher EO; Egorov AIu; Chernikova NA; Filatova EV
    Zh Evol Biokhim Fiziol; 2013; 49(5):352-6. PubMed ID: 25434191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Solla P; Cannas A; Marrosu MG; Marrosu F
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1383-4. PubMed ID: 26453388
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.
    Braun M; Cawello W; Andreas JO; Boekens H; Horstmann R
    J Clin Pharmacol; 2009 Sep; 49(9):1047-55. PubMed ID: 19628729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and psychomotor interactions of new selective COMT inhibitors with clorgyline and nomifensine in levodopa-treated rats and mice.
    Törnwall M; Tuomainen P; Männistö PT
    Arch Int Pharmacodyn Ther; 1992; 320():5-20. PubMed ID: 1300941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist therapy for Parkinson disease and pathological gambling.
    Imamura A; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2006 Dec; 12(8):506-8. PubMed ID: 16723269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia.
    Bendi VS; Shou J; Joy S; Torres-Russotto D
    Parkinsonism Relat Disord; 2018 May; 50():126-127. PubMed ID: 29467094
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of dopamine dysregulation syndrome with valproic acid.
    Epstein J; Madiedo CJ; Lai L; Hayes MT
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E3. PubMed ID: 25093777
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice.
    Tanaka K; Ogawa N
    Neurosci Res; 2005 Jan; 51(1):9-13. PubMed ID: 15596235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Man Made Manic: Levodopa-Carbidopa-Induced Mania in Traumatic Brain Injury.
    Sablaban IM; Sivananthan M
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30677265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible serotonin syndrome with carbidopa-levodopa and linezolid.
    Pettit NN; Alonso V; Wojcik E; Anyanwu EC; Ebara L; Benoit JL
    J Clin Pharm Ther; 2016 Feb; 41(1):101-3. PubMed ID: 26813986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My doctor prescribed Sinemet for my restless legs and it was a catastrophe. Why did you recommend it in a recent article?
    Johns Hopkins Med Lett Health After 50; 1998 Feb; 10(12):8. PubMed ID: 9916583
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
    Lindner MD; Plone MA; Mullins TD; Winn SR; Chandonait SE; Stott JA; Blaney TJ; Sherman SS; Emerich DF
    Exp Neurol; 1997 May; 145(1):130-40. PubMed ID: 9184116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dopaminergic agonists upon body temperature and behavior of spontaneously hypertensive and normotensive rats.
    Martin JR; Quock RM
    Proc West Pharmacol Soc; 1978; 21():451-3. PubMed ID: 567806
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of levodopa/carbidopa on stress response in zebrafish.
    Idalencio R; Lopes TM; Soares SM; Pompermaier A; de Alcantara Barcellos HH; Kalichak F; Fagundes M; de Oliveira CM; Barcellos LJG
    J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2021 May; 207(3):393-399. PubMed ID: 33772638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
    Stocchi F; Marconi S
    Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease.
    Delea TE; Thomas SK; Hagiwara M; Mancione L
    Curr Med Res Opin; 2010 Jul; 26(7):1543-52. PubMed ID: 20429819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.